Society for Immunotherapy of Cancer Annual Meeting

Visit Flagship at SITC 2023 Booth #716. 
November 3-5, 2023. 

We offer a comprehensive set of discovery, translational and clinical testing, and assay development services to support your clinical studies in immune-oncology and immunotherapy. From the selection of high-quality antibodies to the proper selection of platforms, control tissues, and experimental conditions, our approach to assay development is customizable and optimized to obtain the best results.

Attending the SITC Annual Meeting? Meet with us to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program.

  • Customizable multiplex assays, including immunohistochemistry assay development
  • Immuno-oncology biomarker development and validation
  • AI-powered digital pathology solutions
  • Spatial biology and molecular diagnostics analysis
  • Immunotherapy clinical trial support
  • CDx development
  • Regulatory guidance

Our experts work with you to identify and implement the assay development and testing strategies that best meet your research goals and clinical needs. Flagship’s team of pathologists, scientists, and regulatory professionals can effectively assist in all aspects of developing your immunotherapy for cancer treatment.

 

Visit Flagship at SITC 2023 Booth #716 to learn more.

Interested in Partnering with Us?

Validated Assays for Use in Immunotherapy Research & Development.

  • Customizable options optimized to your needs and validation requirements
  • Ability to create multiplex assays to characterize complex cellular interactions

DNA Sequencing & Gene Expression Services

  • Next Generation Sequencing capability utilizing the most advanced systems from Illumina®, including our new NovaSeq™ X Plus
  • Wide range of standard and customizable gene expression panels
  • Combination of standard immunofluorescence techniques with digital optical barcoding technology to perform spatial, highly multiplexed, tissue profiling

Flow Cytometry Tools for Precision Medicine

  • Comprehensive library of CLIA-validated test panels
  • Development of customized assays to address your specific requirements

Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications

  • Expertise in novel biomarker and tissue analyses
  • Regulatory strategy and support
  • Consult with scientific experts

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

2024 ASGCT Annual Meeting

Are you attending the 2024 ASGCT Annual Meeting?With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, the 27th American Society of Gene and Cell Therapy Annual Meeting is the nexus for gene and cell...

AACR Annual Meeting 2024

Meet with us at the AACR Annual Meeting 2024 to learn about our spatial biology solutions. Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the...

Spatial Biology for Immuno-Oncology Summit 2024

Meet with us at the Spatial Biology for Immuno-Oncology Summit.The Spatial Biology for Immuno-Oncology Summit is back for its second year, and Flagship Biosciences is a Program Partner for the event. Join us January 23-25 in San Diego where key industry leaders will...

65th ASH Annual Meeting and Exposition

Meet with us at the American Society of Hematology annual meeting in December. Whether you’re engaged in basic research or drug development, our genomics solutions offer valuable insights to help you achieve your goals. We offer the highest quality results and support...

Spatial Biology for Drug Development Summit

Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...